ENDRA Life Sciences (NASDAQ:NDRA) Releases Earnings Results, Misses Expectations By $5.30 EPS

ENDRA Life Sciences (NASDAQ:NDRA) issued its quarterly earnings data on Monday. The company reported ($9.40) earnings per share for the quarter, missing the consensus estimate of ($4.10) by ($5.30), Zacks reports.

ENDRA Life Sciences Price Performance

NDRA opened at $4.24 on Monday. ENDRA Life Sciences has a 12 month low of $3.15 and a 12 month high of $875.00. The stock’s 50 day moving average price is $4.63 and its 200 day moving average price is $5.97. The stock has a market cap of $2.27 million, a P/E ratio of 0.00 and a beta of 0.43.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.